Could a quick ultrasound replace painful liver biopsies for kids?
NCT ID NCT01072721
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a noninvasive device called FibroScan can accurately measure liver scarring (fibrosis) in children, potentially replacing the need for a liver biopsy. Researchers compared FibroScan results with biopsy results in 264 children aged 6 months to 18 years with various liver diseases. If proven effective, this could make diagnosis and monitoring much easier and less painful for young patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLESTASIS OF PARENTERAL NUTRITION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Necker Hospital
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Can extra doses of an old drug reverse liver scarring?
- Could a yellow tinge predict dangerous hospital infections?
- Muscle quality on MRI may foretell liver transplant success
- Can Weight-Loss surgery beat drugs for advanced liver damage?
- A smartphone tool may help cystic fibrosis patients survive the lung transplant waitlist